Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fan-Fan Hou

Showing results (291-300 of 349) with videos related to

Pageof 35
Sort By:
Clinical Pharmacology and Therapeutics|December 18, 2020
Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney DiseaseJeroen V Koomen, Jasper Stevens, George Bakris, et al.
The New England Journal of Medicine|September 24, 2020
Dapagliflozin in Patients with Chronic Kidney DiseaseHiddo J L Heerspink, Bergur V Stefánsson, Ricardo Correa-Rotter, et al.
American Journal of Nephrology|February 17, 2021
Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance HemodialysisJianping Jiang, Yuanyuan Zhang, Jianghua Chen, et al.
Journal of Lipid Research|November 24, 2016
Association of peripheral differential leukocyte counts with dyslipidemia risk in Chinese patients with hypertension: insight from the China Stroke Primary Prevention TrialYanhong Liu, Xiangyi Kong, Wen Wang, et al.
Theranostics|October 24, 2022
A new LKB1 activator, piericidin analogue S14, retards renal fibrosis through promoting autophagy and mitochondrial homeostasis in renal tubular epithelial cellsCanzhen Liu, Xiaoxu Wang, Xiaonan Wang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 1, 2021
Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trialDavid C Wheeler, Niels Jongs, Bergur V Stefansson, et al.
Investigative Ophthalmology & Visual Science|July 20, 2021
Hypertensive Retinopathy and the Risk of Stroke Among Hypertensive Adults in ChinaXuling Chen, Lishun Liu, Mengyi Liu, et al.
Journal of the American College of Cardiology|May 12, 2018
Platelet Count Affects Efficacy of Folic Acid in Preventing First StrokeXiangyi Kong, Xiao Huang, Min Zhao, et al.
Kidney International Supplements|December 11, 2020
Corrigendum to "Tonelli M, Nkunu V, Varghese C, et al. Framework for establishing integrated kidney care programs in low- and middle-income countries" <i>Kidney Int Suppl.</i> 2020;10:e19-e23Marcello Tonelli, Victoria Nkunu, Cherian Varghese, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 17, 2022
Use of Histologic Parameters to Predict Glomerular Disease Progression: Findings From the China Kidney Biopsy Cohort StudyXiaodong Zhang, Fan Luo, Ruixuan Chen, et al.
Pageof 35

Showing results (291-300 of 349) with videos related to

Sort By:
Pageof 35
Clinical Pharmacology and Therapeutics|December 18, 2020
Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney DiseaseJeroen V Koomen, Jasper Stevens, George Bakris, et al.
The New England Journal of Medicine|September 24, 2020
Dapagliflozin in Patients with Chronic Kidney DiseaseHiddo J L Heerspink, Bergur V Stefánsson, Ricardo Correa-Rotter, et al.
American Journal of Nephrology|February 17, 2021
Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance HemodialysisJianping Jiang, Yuanyuan Zhang, Jianghua Chen, et al.
Journal of Lipid Research|November 24, 2016
Association of peripheral differential leukocyte counts with dyslipidemia risk in Chinese patients with hypertension: insight from the China Stroke Primary Prevention TrialYanhong Liu, Xiangyi Kong, Wen Wang, et al.
Theranostics|October 24, 2022
A new LKB1 activator, piericidin analogue S14, retards renal fibrosis through promoting autophagy and mitochondrial homeostasis in renal tubular epithelial cellsCanzhen Liu, Xiaoxu Wang, Xiaonan Wang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 1, 2021
Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trialDavid C Wheeler, Niels Jongs, Bergur V Stefansson, et al.
Investigative Ophthalmology & Visual Science|July 20, 2021
Hypertensive Retinopathy and the Risk of Stroke Among Hypertensive Adults in ChinaXuling Chen, Lishun Liu, Mengyi Liu, et al.
Journal of the American College of Cardiology|May 12, 2018
Platelet Count Affects Efficacy of Folic Acid in Preventing First StrokeXiangyi Kong, Xiao Huang, Min Zhao, et al.
Kidney International Supplements|December 11, 2020
Corrigendum to "Tonelli M, Nkunu V, Varghese C, et al. Framework for establishing integrated kidney care programs in low- and middle-income countries" <i>Kidney Int Suppl.</i> 2020;10:e19-e23Marcello Tonelli, Victoria Nkunu, Cherian Varghese, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 17, 2022
Use of Histologic Parameters to Predict Glomerular Disease Progression: Findings From the China Kidney Biopsy Cohort StudyXiaodong Zhang, Fan Luo, Ruixuan Chen, et al.
Pageof 35